Author:
Rocque Brittany,Kahn Jeffrey,Emamaullee Juliet
Publisher
Springer Science and Business Media LLC
Subject
Gastroenterology,Physiology
Reference12 articles.
1. Geneva, S. W. H. O. Progress report on access to hepatitis C treatment: focus on overcoming barriers in low- and middle-income countries, March 2018. Who (2018) doi: Licence: CC BY-NC-SA 3.0 IGO.
2. Forner A, Reig M, Bruix J. Hepatocell Carcinoma. Lancet. 2018. https://doi.org/10.1016/S0140-6736(18)30010-2.
3. Ohishi W, Oka M, Mukoubayashi C, et al. Risk factors for hepatocellular carcinoma in a Japanese population: a nested case-control study. Cancer Epidemiol Biomark Prev. 2008. https://doi.org/10.1158/1055-9965.EPI-07-2806.
4. Asahina Y, Izumi N, Hiromitsu K, et al. JSH guidelines for the management of Hepatitis C Virus infection: a 2016 update for genotype 1 and 2. Hepatol Res. 2016. https://doi.org/10.1111/hepr.12645.
5. Nishiguchi S, Shiomi S, Nakatani S, et al. Prevention of hepatocellular carcinoma in patients with chronic active hepatitis C and cirrhosis. Lancet. 2001. https://doi.org/10.1016/S0140-6736(00)03595-9.